- Home
- DYN vs ESBA Comparison
DYN vs ESBA Comparison
Compare DYN & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ESBA
- Stock Information
- Founded
- DYN 1984
- ESBA N/A
- Country
- DYN United States
- ESBA United States
- Employees
- DYN N/A
- ESBA N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ESBA
- Sector
- DYN Health Care
- ESBA
- Exchange
- DYN Nasdaq
- ESBA NYSE
- Market Cap
- DYN 2.6B
- ESBA 2.2B
- IPO Year
- DYN 2020
- ESBA 2013
- Fundamental
- Price
- DYN $9.23
- ESBA $7.48
- Analyst Decision
- DYN Strong Buy
- ESBA
- Analyst Count
- DYN 12
- ESBA 0
- Target Price
- DYN $47.73
- ESBA N/A
- AVG Volume (30 Days)
- DYN 1.8M
- ESBA 8.4K
- Earning Date
- DYN 05-01-2025
- ESBA 01-01-0001
- Dividend Yield
- DYN N/A
- ESBA 1.80%
- EPS Growth
- DYN N/A
- ESBA N/A
- EPS
- DYN N/A
- ESBA 0.28
- Revenue
- DYN N/A
- ESBA $763,152,000.00
- Revenue This Year
- DYN N/A
- ESBA N/A
- Revenue Next Year
- DYN N/A
- ESBA N/A
- P/E Ratio
- DYN N/A
- ESBA $27.71
- Revenue Growth
- DYN N/A
- ESBA 3.19
- 52 Week Low
- DYN $9.17
- ESBA $7.41
- 52 Week High
- DYN $47.45
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- DYN 26.62
- ESBA 28.83
- Support Level
- DYN $10.72
- ESBA $7.41
- Resistance Level
- DYN $12.00
- ESBA $7.86
- Average True Range (ATR)
- DYN 0.76
- ESBA 0.15
- MACD
- DYN -0.11
- ESBA -0.01
- Stochastic Oscillator
- DYN 1.52
- ESBA 10.14
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.